𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Influences of anti-tumour necrosis factor agents on postoperative recovery in patients with rheumatoid arthritis

✍ Scribed by Yuji Hirano; Toshihisa Kojima; Yasuhide Kanayama; Tomone Shioura; Masatoshi Hayashi; Daihei Kida; Atsushi Kaneko; Yoshito Eto; Naoki Ishiguro

Publisher
Springer
Year
2010
Tongue
English
Weight
130 KB
Volume
29
Category
Article
ISSN
0770-3198

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

B cell depletion may be more effective t
B cell depletion may be more effective than switching to an alternative anti–tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti–tumor necrosis factor agents
✍ Axel Finckh; Adrian Ciurea; Laure Brulhart; Diego Kyburz; Burkhard Möller; Silvi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views

## Abstract ## Objective Patients with rheumatoid arthritis (RA) in whom the response to anti–tumor necrosis factor (anti‐TNF) therapy is inadequate have several therapeutic options, such as switching to an alternative anti‐TNF agent or initiating B cell–depleting therapy with rituximab (RTX). Alt

Outcomes after switching from one anti–t
Outcomes after switching from one anti–tumor necrosis factor α agent to a second anti–tumor necrosis factor α agent in patients with rheumatoid arthritis: Results from a large UK national cohort study
✍ Kimme L. Hyrich; Mark Lunt; Kath D. Watson; Deborah P. M. Symmons; Alan J. Silma 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 1 views

## Abstract ## Objective Patients with rheumatoid arthritis (RA) who experience treatment failure with one anti–tumor necrosis factor (anti‐TNF) agent, due to either inefficacy or toxicity, are frequently switched to a second anti‐TNF agent, although the benefits of switching are unknown. The pres